The AI workspace for legal professionals
- Legal research with access to more than 1 million sources
- Document automation
- Matter management
- Hosted in the EU and Switzerland
Try it free for 14 days (10 questions/day during trial)
The AI workspace for legal professionals
Try it free for 14 days (10 questions/day during trial)
24-1131•Jianyi Zhang v. Us Fda
UNPUBLISHED
UNITED STATES COURT OF APPEALS
FOR THE FOURTH CIRCUIT
No. 24-1131
JIANYI ZHANG,
Plaintiff - Appellant,
v.
US FDA,
Defendant - Appellee.
Appeal from the United States District Court for the District of Maryland, at Baltimore.
George L. Russell, III, Chief District Judge. (1:22-cv-03126-GLR)
Submitted: May 30, 2024 Decided: June 4, 2024
Before GREGORY and HARRIS, Circuit Judges, and MOTZ, Senior Circuit Judge.
Affirmed by unpublished per curiam opinion.
Jianyi Zhang, Appellant Pro Se. Michael Jackman Wilson, OFFICE OF THE UNITED
STATES ATTORNEY, Baltimore, Maryland, for Appellee.
Unpublished opinions are not binding precedent in this circuit.
-- 1 of 2 --
2
PER CURIAM:
Jianyi Zhang appeals the district court’s order dismissing Zhang’s complaint
alleging several constitutional violations filed pursuant to 42 U.S.C. § 1983 and Federal
Tort Claims Act, 28 U.S.C. §§ 1346(b), 2671 to 2680. We have reviewed the record and
find no reversible error. Accordingly, we affirm the district court’s order. Zhang v. U.S.
Food & Drug Admin., No. 1:22-cv-03126-GLR (D. Md. Jan. 18, 2024). We dispense with
oral argument because the facts and legal contentions are adequately presented in the
materials before this court and argument would not aid the decisional process.
AFFIRMED
-- 2 of 2 --
Connect Omnilex to search the legal corpus from your AI assistant.